Hormone Therapy

Effects of Cross-Sex Hormone Therapy on BMD of Transgender People

Effects of Cross-Sex Hormone Therapy on BMD of Transgender People

By

The effect of 1 year of cross-sex hormone therapy on bone mineral density was examined in transgender men and women.

Cross-Sex Hormone Therapy: What Are the Long-Term Risk Factors?

Cross-Sex Hormone Therapy: What Are the Long-Term Risk Factors?

Primary prevention of cardiovascular disease through risk factor modification, including tobacco cessation, maintenance of a body mass index, and management of abnormal lipid levels, diabetes, and hypertension, is of great importance for the health of transgender individuals.

Decreased Mortality, CAC Scores With Hormone Replacement Therapy

Decreased Mortality, CAC Scores With Hormone Replacement Therapy

By

HRT in postmenopausal women was linked to lower CAC scores and a lower risk of long-term, all-cause mortality.

Hormone Therapy Linked to Reduced Risk for Mortality From Vascular Dementia

Hormone Therapy Linked to Reduced Risk for Mortality From Vascular Dementia

By

In postmenopausal women taking hormone therapy, risk for death from vascular dementia appeared to be reduced.

Venous Thromboembolism Risk Higher in Men Starting Testosterone Therapy

Venous Thromboembolism Risk Higher in Men Starting Testosterone Therapy

Starting testosterone treatment is associated with an increased risk of venous thromboembolism (VTE), peaking within 6 months and declining thereafter.

Implantable Testosterone Pellets Associated With Small Hematocrit Increase

Implantable Testosterone Pellets Associated With Small Hematocrit Increase

Men treated with implantable testosterone pellets have a statistically significant increase in mean hematocrit, but it is unlikely to be clinically relevant.

Bone Health Improved With Menopausal Hormone Therapy

Bone Health Improved With Menopausal Hormone Therapy

By

The use of menopausal hormone therapy was associated with improved bone mineral density and better bone microarchitecture.

Does Birth Control Boost Vitamin D Levels in Women?

Does Birth Control Boost Vitamin D Levels in Women?

By

Use of estrogen-containing contraceptives were linked to significantly higher vitamin D levels.

Hormone Replacement Therapy vs Combination Oral Contraceptive for Bone Health in Premature Ovarian Failure

Hormone Replacement Therapy vs Combination Oral Contraceptive for Bone Health in Premature Ovarian Failure

By

In women with premature ovarian failure, hormone replacement therapy was associated with greater increases in bone mineral density.

Assessing the Impact of Postmenopausal Hormone Therapy on Cardiovascular Health

Assessing the Impact of Postmenopausal Hormone Therapy on Cardiovascular Health

By

In light of ELITE trial results, estradiol hormone therapy may have a role in coronary heart disease treatment.

Testosterone Gel Moderately Improved Sexual Function in Older Men

Testosterone Gel Moderately Improved Sexual Function in Older Men

Men using testosterone gel experienced improvements in sex drive, sexual activity, and erectile function.

Hormone Therapy May Increase Multiple Sclerosis Risk in Some Transgender Patients

Hormone Therapy May Increase Multiple Sclerosis Risk in Some Transgender Patients

By

Researchers hypothesized that an altered balance of sex hormones in men with gender identity disorder would increase the risk of MS.

Estrogen May Restore Memory in Young Athletes With Amenorrhea

Estrogen May Restore Memory in Young Athletes With Amenorrhea

By

Verbal memory and cognitive flexibility improved after 6 months of estrogen replacement therapy.

Oral Progesterone May Attenuate Drug-Induced QT Interval Lengthening

Oral Progesterone May Attenuate Drug-Induced QT Interval Lengthening

Findings in healthy females who received progesterone or placebo for 7 days.

VIDEO: Hormone Treatment Paradigms in Transgender Medicine

VIDEO: Hormone Treatment Paradigms in Transgender Medicine

Clinicians should consider the benefits and risks of hormone therapy when treating this patient population.

ACOG: Vaginal Estrogen May Be Considered for Breast Cancer Survivors

ACOG: Vaginal Estrogen May Be Considered for Breast Cancer Survivors

Use of vaginal estrogen should be carefully considered by women with a history of estrogen-dependent breast cancer, according to a Committee Opinion published in Obstetrics & Gynecology.

Stroke Risk Higher in Women on Hormone Therapy With Worsening Migraines

Stroke Risk Higher in Women on Hormone Therapy With Worsening Migraines

More than 20% of women currently using hormone replacement therapy experienced an increase in migraine severity.

T Trial: Testosterone Therapy May Have Modest Benefits for Older Men

T Trial: Testosterone Therapy May Have Modest Benefits for Older Men

By

Sexual function and mood and depressive symptoms were improved in older men who received testosterone therapy.

Adjuvant Endocrine Therapy for Breast Cancer Associated With Increased Symptom Burden

Adjuvant Endocrine Therapy for Breast Cancer Associated With Increased Symptom Burden

Patients treated with adjuvant endocrine therapy for primary breast cancer have considerable symptom burden.

Menopause Symptom Treatment Guideline Focuses on Individualized Approach

Menopause Symptom Treatment Guideline Focuses on Individualized Approach

By

An individualized approach based on patient preferences is important for treatment of menopause.

Transition Treatment for Transgender Patients Considered Cost-Effective

Transition Treatment for Transgender Patients Considered Cost-Effective

Surgical and hormone expenses are less than those that treat complications of not transitioning.

Progesterone Failed to Improve Outcomes in Women with Recurrent Miscarriages

Progesterone Failed to Improve Outcomes in Women with Recurrent Miscarriages

By

Progesterone therapy during the first trimester did not increase live birth rates in women with recurrent miscarriages.

Hormonal Status Affects Link Between Genetic Variation, Carotid Intima-Medial Thickness

Hormonal Status Affects Link Between Genetic Variation, Carotid Intima-Medial Thickness

SNPs within the innate immunity pathway altered the treatment effect on four-year change in CIMT

Hormone Therapy, Age at Menopause Associated With Basal Cell Carcinoma Risk

Hormone Therapy, Age at Menopause Associated With Basal Cell Carcinoma Risk

An increased risk was seen with late age at natural menopause and with any use of menopausal hormone therapy.

Hormone Therapy Earlier in Menopause May Lower Risk for Developing CHD

Hormone Therapy Earlier in Menopause May Lower Risk for Developing CHD

By

Initiating hormone therapy earlier in menopause may lower risk for later development of coronary heart disease.

Compounded Hormone Use Common Among Menopausal Hormone Therapy Users

Compounded Hormone Use Common Among Menopausal Hormone Therapy Users

By

One-third of women taking hormone therapy at menopause are using compounded hormones.

Long-Term Treatment Outcomes to Soon Be Studied in Transgender Youth

Long-Term Treatment Outcomes to Soon Be Studied in Transgender Youth

By

The first study in the United States to investigate the long-term outcomes of medical treatment for transgender youth is set to begin in the near future.

Bioidentical Hormones: Why Is There Controversy and How Do You Stay Safe?

Bioidentical Hormones: Why Is There Controversy and How Do You Stay Safe?

By

Women seeking relief from menopausal symptoms must be aware of the risks, benefits of different treatment options.

Menopausal Hormone Therapy May Hike Risk for Lower GI Bleeding

Menopausal Hormone Therapy May Hike Risk for Lower GI Bleeding

No difference in incidence of upper GI bleeding in menopausal hormone therapy users vs. non-users.

Cardiovascular Benefit Absent With Hormone Therapy in Menopause

Cardiovascular Benefit Absent With Hormone Therapy in Menopause

Another study looking at the potential dangers of hormone replacement therapy for menopausal symptoms suggests the treatment yields no cardiovascular benefit.

Sign Up for Free e-Newsletters